Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19

NCT04385186 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Infections, Coronavirus

Interventions

DRUG: Inactivated convalescent plasma
DRUG: Support treatment

Sponsor

National Blood Center Foundation, Hemolife